Spots Global Cancer Trial Database for attention
Every month we try and update this database with for attention cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training | NCT05000905 | Pediatric Cance... | Adaptive Attent... Questionnaires | 7 Years - 17 Years | University of California, San Francisco | |
Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome | NCT02859389 | Leukemia Down Syndrome | - | St. Jude Children's Research Hospital | ||
Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms | NCT01641068 | Breast Carcinom... Cancer Survivor Cognitive Side ... Malignant Femal... | Cognitive Inter... Educational Int... Functional Magn... Memory Interven... Quality-of-Life... Questionnaire A... | 21 Years - 90 Years | University of Washington | |
Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training | NCT05000905 | Pediatric Cance... | Adaptive Attent... Questionnaires | 7 Years - 17 Years | University of California, San Francisco | |
Cognitive Rehabilitation of Glioma Patients | NCT00256425 | Glioma Cognition Disor... | Cognitive rehab... | 18 Years - 70 Years | UMC Utrecht | |
Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects | NCT00255138 | Cancer Cognitive Late ... | Atomoxetine | 6 Years - 18 Years | Temple University | |
The Use of a Quality of Life Questionnaire in Patients With Lung Cancer | NCT01213745 | Lung Cancer | Intervention Attention Control | 18 Years - | Royal Marsden NHS Foundation Trust | |
Vision, Attention and Reading in Neurofibromatosis Type 1 (NF1) Children | NCT03518710 | Neurofibromatos... | Neuropsychologi... Evaluation of t... | 7 Years - 9 Years | University Hospital, Toulouse | |
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy | NCT01382082 | Breast Cancer Lymphoma | 21 Years - | University of Rochester | ||
Cognitive Rehabilitation of Glioma Patients | NCT00256425 | Glioma Cognition Disor... | Cognitive rehab... | 18 Years - 70 Years | UMC Utrecht | |
Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment | NCT00688376 | Attention Impai... | Donepezil hydro... Placebo | 6 Years - 17 Years | Eisai Inc. | |
Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome | NCT02859389 | Leukemia Down Syndrome | - | St. Jude Children's Research Hospital | ||
Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer | NCT03619083 | Breast Cancer | SAE battery Assessments | 40 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects | NCT00255138 | Cancer Cognitive Late ... | Atomoxetine | 6 Years - 18 Years | Temple University |